Curious about Neurocrine (NBIX) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Wall Street analysts forecast that Neurocrine Biosciences (NBIX) will report quarterly earnings of $1.04 per share in its upcoming release, pointing to a year-over-year increase of 231.7%. It is anticipated that revenues will amount to$ 512.21 million, exhibiting an increase of 21.8% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 3.8% to its current level. This demonstrates the covering analysts' collective reassessment of the ...